SC 13G: Kyverna Therapeutics, Inc.

AI Summary

SC 13G filing by Kyverna Therapeutics, Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.00001 — Inc. (Name of Issuer) Common stock, $0.00001 par value per share (Title of Class o

Filing Documents

• tm246946d1_sc13g.htm (SC 13G) — 118KB
• 0001104659-24-026552.txt ( ) — 119KB

From the Filing

SC 13G 1 tm246946d1_sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Kyverna Therapeutics, Inc. (Name of Issuer) Common stock, $0.00001 par value per share (Title of Class of Securities) 501976104 (CUSIP Number) February 12, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 501976104 1. Names of Reporting Persons Northpond Ventures, LP 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) (1) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting Power 450,000 (2) 7. Sole Dispositive Power 0 8. Shared Dispositive Power 450,000 (2) 9. Aggregate Amount Beneficially Owned by Each Reporting Person 450,000 (2) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 1.0% (3) 12. Type of Reporting Person (See Instructions) PN (1) This Schedule 13G is filed by Northpond Ventures, LP (“Northpond”), Northpond Ventures GP, LLC (“Northpond GP”), Northpond Ventures III, LP (“Northpond III”), Northpond Ventures III GP, LLC (“Northpond III GP”) and Michael P. Rubin (“Rubin” and, with Northpond, Northpond GP, Northpond III and Northpond III GP, collectively, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G. (2) The shares are held by Northpond. Northpond GP is the general partner of Northpond and Rubin is the managing member of Northpond GP. As such, Northpond GP and Rubin have shared dispositive and voting power over the shares held by Northpond and may be deemed to have indirect beneficial ownership of the shares held by Northpond. (3) This percentage is calculated based on 42,997,525 shares of Common Stock outstanding as of February 12, 2024 upon the closing of the Issuer’s initial public offering, as reported in the prospectus dated February 7, 2024 filed by the Issuer with the SEC on February 8, 2024. 2 CUSIP No. 501976104 1. Names of Reporting Persons Northpond Ventures GP, LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) (1) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting Power 450,000 (2) 7. Sole Dispositive Power 0 8. Shared Dispositive Power 450,000 (2) 9. Aggregate Amount Beneficially Owned by Each Reporting Person 450,000 (2) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 1.0% (3) 12. Type of Reporting Person (See Instructions) OO (1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G. (2) The shares are held by Northpond. Northpond GP is the general partner of Northpond and Rubin is the managing member of Northpond GP. As such, Northpond GP and Rubin have shared dispositive and voting power over the shares held by Northpond and may be deemed to have indirect beneficial ownership of the shares held by Northpond. (3) This percentage is calculated based on 42,997,525 shares of Common Stock outstanding as of February 12, 2024 upon the closing of the Issuer’s initial public offering, as reported in the prospectus dated February 7, 2024 filed by the Issuer with the SEC on February 8, 2024. 3 CUSIP No. 501976104 1. Names of Reporting Persons Northpond Ventures III, LP 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) (1) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting Power 2,805,426

View Full Filing

View this SC 13G filing on SEC EDGAR